Invesco LLC Buys 2,457 Shares of Agilent Technologies, Inc. $A

Key Points

• Invesco LLC increased its stake in Agilent Technologies by 10.2%, acquiring an additional 2,457 shares to total 26,519 shares, which is valued at approximately $3.13 million.
• Agilent Technologies reported a 10.1% year-over-year revenue increase with earnings meeting the consensus estimate at $1.37 EPS, while providing fiscal year 2025 guidance of 5.560-5.590 EPS.
• The company declared a quarterly dividend of $0.248 per share, with an annualized dividend yield of 0.8%, reflecting a payout ratio of 23.24%.

Invesco LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 10.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,519 shares of the medical research company's stock after purchasing an additional 2,457 shares during the period. Agilent Technologies accounts for approximately 1.2% of Invesco LLC's holdings, making the stock its 23rd biggest position. Invesco LLC's holdings in Agilent Technologies were worth $3,130,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Agilent Technologies by 13.5% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,674 shares of the medical research company's stock valued at $4,279,000 after purchasing an additional 4,362 shares in the last quarter. Assenagon Asset Management S.A. grew its stake in shares of Agilent Technologies by 8.3% in the 1st quarter. Assenagon Asset Management S.A. now owns 30,827 shares of the medical research company's stock worth $3,606,000 after buying an additional 2,371 shares in the last quarter. Alps Advisors Inc. increased its holdings in shares of Agilent Technologies by 29.5% in the 1st quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company's stock worth $1,563,000 after buying an additional 3,040 shares during the last quarter. D.A. Davidson & CO. raised its position in shares of Agilent Technologies by 30.4% during the 1st quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company's stock valued at $1,108,000 after buying an additional 2,207 shares in the last quarter. Finally, LGT Capital Partners LTD. raised its position in Agilent Technologies by 7.6% during the first quarter. LGT Capital Partners LTD. now owns 768,252 shares of the medical research company's stock valued at $89,870,000 after purchasing an additional 54,302 shares during the period.

Agilent Technologies Trading Up 1.3%

NYSE A opened at $123.45 on Monday. The stock has a market cap of $35.00 billion, a PE ratio of 28.98, a PEG ratio of 4.03 and a beta of 1.24. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The company's 50-day moving average price is $121.15 and its 200-day moving average price is $115.91. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm's quarterly revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.8%. Agilent Technologies's dividend payout ratio (DPR) is currently 23.24%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Barclays reiterated an "equal weight" rating and issued a $125.00 target price on shares of Agilent Technologies in a report on Friday, August 29th. Robert W. Baird raised their price target on Agilent Technologies from $141.00 to $142.00 and gave the stock an "outperform" rating in a research report on Thursday, August 28th. Evercore ISI cut their price objective on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a research report on Thursday, August 28th. Wells Fargo & Company increased their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a research note on Monday, September 15th. Finally, Wall Street Zen lowered shares of Agilent Technologies from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and an average price target of $140.08.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.